Stock Events

Stock Events

Shuttle Pharmaceuticals

$5.09

22

+$0.22+4.52%Thursday 04:01

Statistics

Day High

5.09

Day Low

5.09

52W High

5.85

52W Low

0.4109

Volume

-

Avg. Volume

-

Mkt Cap

24.25M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Financials

-Profit Margin

Unprofitable

2020

2021

2022

2023

2024

2025

0Revenue

-11.72MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHPH.BOATS. It's not an investment recommendation.

Lloyds Banking Group

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for many of the same diseases targeted by Shuttle Pharmaceuticals, making them direct competitors in the pharmaceutical market.

Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines, competing in similar therapeutic areas as Shuttle Pharmaceuticals.

Bristol-Myers Squibb

Bristol-Myers Squibb Company is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, overlapping with Shuttle Pharmaceuticals' mission.

Johnson & Johnson

Johnson & Johnson is a comprehensive healthcare firm that produces pharmaceuticals, medical devices, and consumer health products, competing across several of Shuttle Pharmaceuticals' key areas.

AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, directly competing with Shuttle Pharmaceuticals in the area of drug development and innovation.

Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics, making it a competitor in the biopharmaceutical field alongside Shuttle Pharmaceuticals.

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, directly competing with Shuttle Pharmaceuticals.

Novartis AG is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Shuttle Pharmaceuticals in various therapeutic areas.

Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics. It is a direct competitor in the development of innovative drugs and personalized healthcare solutions.

AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, competing in similar fields as Shuttle Pharmaceuticals.

About

Shuttle Pharmaceuticals Holdings, Inc., in conjunction with its subsidiary Shuttle Pharmaceuticals, Inc., is committed to the identification, advancement, and commercialization of pharmaceutical agents crafted to heighten the susceptibility of cancerous cells to radiation therapy. Its current portfolio of clinical-phase treatments features Ropidoxuridine, an orally administered halogenated pyrimidine, which is intended for individuals afflicted with brain tumors and soft tissue sarcomas. Additionally, the company is progressing Doranidazole, an injectable compound designed to make oxygen-deprived tumor cells more responsive to radiation, targeting malignancies of the pancreas, lungs, and liver. This enterprise was established in 2012 and maintains its principal operations in Rockville, Maryland.

Show More

CEO

ISIN

US8256934014

Listings

0 Comments

Share your thoughts

FAQs

What is Shuttle Pharmaceuticals stock price today?▼

The current price of SHPH.BOATS is $5.09 USD — it has increased by +4.52% in the past 24 hours. Watch Shuttle Pharmaceuticals stock price performance more closely on the chart.

What is Shuttle Pharmaceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Shuttle Pharmaceuticals stocks are traded under the ticker SHPH.BOATS.

What is Shuttle Pharmaceuticals market cap?▼

Today Shuttle Pharmaceuticals has the market capitalization of 24.25M

What is Shuttle Pharmaceuticals revenue for the last year?▼

Shuttle Pharmaceuticals revenue for the last year amounts to 0 USD.

What is Shuttle Pharmaceuticals net income for the last year?▼

SHPH.BOATS net income for the last year is -11.72M USD.

In which sector is Shuttle Pharmaceuticals located?▼

Shuttle Pharmaceuticals operates in the Other sector.

When did Shuttle Pharmaceuticals complete a stock split?▼

The last stock split for Shuttle Pharmaceuticals was on June 11, 2026 with a ratio of 1:10.